GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

ScripsAmerica SCRCQ · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About ScripsAmerica

Its shares trade under the ticker SCRCQ. It has been listed since 30 May 2012. In the fiscal year to 31 December 2014, it reported revenue of $30.9m and a net loss of $4.7m. At that date it held total assets of $5.6m and shareholders' equity of −$3.2m.

ScripsAmerica, Inc. operates as a provider of pharmaceutical supply chain management company. The company is headquartered in Clifton, New Jersey. The company went IPO on 2012-05-30. The firm's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). The company also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Food & Staples Retailing
Listed since
30 May 2012
Employees
2

Leadership

Pay as last reported

  • Mr. Brian EttingerChairman of the Board, Chief Executive Officer, since 2011
  • Mr. Adam BrosiusPresident, Director, since 2015
  • Mr. Jeffrey AndrewsChief Financial Officer$424,864
  • Mr. Pelligrino CertaDirector
  • Dr. Joseph CamardoIndependent Director
  • Dr. Michael ImperialeIndependent Director
  • Mr. William LewisIndependent Director
  • Mr. Andrius PranskeviciusIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • ScripsAmerica Inc possesses several strengths that contribute to its success in the market:

Weaknesses

  • Despite its strengths, ScripsAmerica Inc is faced with certain weaknesses that may hinder its progress:

Opportunities

  • ScripsAmerica Inc can leverage the following opportunities to further enhance its market position:

Threats

  • ScripsAmerica Inc faces certain threats that may pose challenges to its growth and profitability:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.